Stocks To Buy: Archean Chemical, PNB Housing Finance, Voltas, Indian Overseas Bank, Rashtriya Chemicals
Analysts chose stocks from fertilisers, financial services sectors for Tuesday's session.
Analysts and brokerage chose Archean Chemical Industries Ltd., Indian Overseas Bank Ltd., PNB Housing Finance Ltd., Rashtriya Chemical & Fertilizers Ltd., and Voltas Ltd. for Tuesday's session.
Kushbohra.com Founder Kush Bohra, The Streets Fund Manager & Trading Strategist Kunal Rambhia, and IDBI Capital Technical & Derivatives, Retail Research Head Brijesh Ali shared their views on the above mentioned stocks.
For more stock recommendation click here.
Archean Chemical Industries
Archean Chemical Industries gets a buy recommendation from Bohra for Tuesday's session. The target price for the stock is Rs 675 apiece, which implied 4.1% upside from Monday's close price. The stop loss is at Rs 625.
Out of 18 analysts tracking the company, six maintain a 'buy' rating, two recommend a 'hold', according to Bloomberg data. The average 12-month consensus price target implies an upside of 5.9%.
PNB Housing Finance
Bohra suggested a buy for the stock. The target price is at Rs 1,145 apiece, which implied 1.6% upside from Monday's close price. The stop loss is at Rs 1,105 apiece.
Twelve analysts tracking the company maintain a 'buy' rating, according to Bloomberg data. The average 12-month consensus price target implies an upside of 8.1%.
Indian Overseas Bank
Rambhia suggests to buy Indian Overseas Bank at target price Rs 45 apiece. The target price implied a 11.0% upside from Monday's close price. The stop loss is at Rs 38 apiece.
Rashtriya Chemical & Fertilizers
Rambhia gives a buy to the Rashtriya Chemical & Fertilizers Ltd. The target price is at Rs 175 apiece, which implied a 6.6% upside from Monday's close price. The stop loss is at Rs 160 apiece.
Voltas
Brijesh Ali suggested a buy for Voltas. The target price for the stock is Rs 1,350 apiece, which implied 4.9% upside from Monday's close price. The stop loss is at Rs 1,258 apiece.
Out of 41 analysts tracking the company, 28 maintain a 'buy' rating, eight recommend a 'hold,' and five suggest 'sell', according to Bloomberg data. The average 12-month consensus price target implies an upside of 12.1%
